Loading…
Reported covered position: House Ed & Workforce Cte; Senate HELP Cte
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2014 · fourth_quarter · Q4
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
Source: Senate LDA
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796)
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: (1) Provisions related to reassignment of disposable negative pressure wound therapy to APC 0015; (2) Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)
Global Investment in American Jobs Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Global Investment in American Jobs Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Global Investment in American Jobs Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Global Investment in American Jobs Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413) Consolidated Appropriations Act of 2014 (H.R. 3547)FY2015 NIH Funding levels
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
Comprehensive Care Payment Innovation Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796)
Comprehensive Care Payment Innovation Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
Comprehensive Care Payment Innovation Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: (1) Provisions related to reassignment of disposable negative pressure wound therapy to APC 0015; (2) Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)
Comprehensive Care Payment Innovation Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10.
Protecting Access to Medicare Act of 2014
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
Protecting Access to Medicare Act of 2014
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: (1) Provisions related to reassignment of disposable negative pressure wound therapy to APC 0015; (2) Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)
Protecting Access to Medicare Act of 2014
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10.
Protect Medical Innovation Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Protect Medical Innovation Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Protect Medical Innovation Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Protect Medical Innovation Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Protecting the Integrity of Medicare Act of 2014
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
Global Investment in American Jobs Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Global Investment in American Jobs Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Global Investment in American Jobs Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Global Investment in American Jobs Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413) Consolidated Appropriations Act of 2014 (H.R. 3547)FY2015 NIH Funding levels
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796)
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: (1) Provisions related to reassignment of disposable negative pressure wound therapy to APC 0015; (2) Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
Preventing Regulatory Overreach To Enhance Care Technology Act of 2014
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).
Preventing Regulatory Overreach To Enhance Care Technology Act of 2014
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
Preventing Regulatory Overreach To Enhance Care Technology Act of 2014
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: (1) Provisions related to reassignment of disposable negative pressure wound therapy to APC 0015; (2) Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10.
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796)
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013.
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013. SGR Repeal and Medicare Beneficiary Access Act of 2013 (S. 1871).
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Protect Medical Innovation Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Protect Medical Innovation Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013. SGR Repeal and Medicare Beneficiary Access Act of 2013 (S. 1871).
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013.
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013. SGR Repeal and Medicare Beneficiary Access Act of 2013 (S. 1871).
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2014 · third_quarter · Q3
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: (1) Provisions related to reassignment of disposable negative pressure wound therapy to APC 0015; (2) Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2014 · second_quarter · Q2
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10.
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2014 · first_quarter · Q1
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413) Consolidated Appropriations Act of 2014 (H.R. 3547)FY2015 NIH Funding levels
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2013 · fourth_quarter · Q4
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013. SGR Repeal and Medicare Beneficiary Access Act of 2013 (S. 1871).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2013 · third_quarter · Q3
FY 2014 medical device user fees for the Food and Drug Administration.
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE